Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, LakeShore Biopharma Co's Enterprise Value is $184.54 Mil.
LakeShore Biopharma Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-39.13 Mil. Therefore, LakeShore Biopharma Co's EV-to-EBIT ratio for today is -4.72.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, LakeShore Biopharma Co's Enterprise Value is $184.54 Mil.
LakeShore Biopharma Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-33.57 Mil. Therefore, LakeShore Biopharma Co's EV-to-EBITDA ratio for today is -5.50.
LakeShore Biopharma Co Enterprise Value Historical Data
The historical data trend for LakeShore Biopharma Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LakeShore Biopharma Co's Enterprise Value
For the Biotechnology subindustry, LakeShore Biopharma Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LakeShore Biopharma Co's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where LakeShore Biopharma Co's Enterprise Value falls into.
LakeShore Biopharma Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
LakeShore Biopharma Co's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LakeShore Biopharma Co (NAS:LSB) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
LakeShore Biopharma Co's current Enterprise Value is $184.54 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. LakeShore Biopharma Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-39.13 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
LakeShore Biopharma Co's EV-to-EBITDA for today is:
LakeShore Biopharma Co's current Enterprise Value is $184.54 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. LakeShore Biopharma Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-33.57 Mil.
LakeShore Biopharma Co's current Enterprise Value is $184.54 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. LakeShore Biopharma Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $79.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LakeShore Biopharma Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of LakeShore Biopharma Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.
LakeShore Biopharma Co (LakeShore Biopharma Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSB has been successfully added to your